25-Hydroxyvitamin D Concentrations and Clostridium difficile Infection: A Meta-Analysis

Abstract

Background: Well-known risk factors for Clostridium difficile infection (CDI) are exposure to antibiotics and gastric acid suppressants. Recent studies have provided some evidence of an association between hypovitaminosis D and the risk of CDI. Therefore, this meta-analysis aimed to pool all the existing evidence to investigate the association between 25-hydroxyvitamin D (25[OH]D) and CDI. Methods: A systematic search was conducted in 3 databases (PubMed, Embase, and Web of Sciences) for epidemiological studies that examined the association between mean 25(OH)D concentrations and CDI as well as between 25(OH)D status and CDI severity or recurrence. 25(OH)D status was defined as “lower” or “higher” at a threshold concentration of <20 or ≥20 ng/mL, respectively. Pooled effect sizes were computed using the inverse variance heterogeneity model of meta-analysis. Results: Eight publications (n = 4479 patients) were included in the meta-analysis. The mean concentration of 25(OH)D in patients with CDI was 3.54 ng/mL (95% confidence interval [CI], 0.39–6.89 ng/mL) lower than in patients without CDI. Patients with lower 25(OH)D status had a higher odds (odds ratio [OR], 1.61; 95% CI, 1.02–2.53) of developing severe CDI compared with those with a higher 25(OH)D status. No significant association was found between 25(OH)D status and CDI recurrence. Conclusion: The results of this meta-analysis suggest that lower mean concentrations of 25(OH)D were associated with CDI. A lower 25(OH)D status increased the odds of severe CDI but not of CDI recurrence.

Keywords

infection recurrence severity vitamin D 25-hydroxyvitamin D

Get full access to this article

View all access options for this article.

References

Lessa

Gould

McDonald

. Current status of Clostridium difficile infection epidemiology. Clin Infect Dis. 2012;55:S65-S70.

O’Brien

Lahue

Caro

Davidson

. The emerging infectious challenge of Clostridium difficile-associated disease in Massachusetts hospitals: clinical and economic consequences. Infect Control Hosp Epidemiol. 2007;28:1219-1227.

Dubberke

Olsen

. Burden of Clostridium difficile on the healthcare system. Clin Infect Dis. 2012;55:S88-S92.

Ananthakrishnan

Cagan

Gainer

. Higher plasma vitamin D is associated with reduced risk of Clostridium difficile infection in patients with inflammatory bowel diseases. Aliment Pharmacol Ther. 2014;39:1136-1142.

Abdelfatah

Nayfe

Moftakhar

. Low vitamin D level and impact on severity and recurrence of Clostridium difficile infections. J Investig Med. 2015;63:17-21.

van der Wilden

Fagenholz

Velmahos

Quraishi

Schipper

Camargo

Jr.

Vitamin D status and severity of Clostridium difficile infections: a prospective cohort study in hospitalized adults. JPEN J Parenter Enteral Nutr. 2015;39:465-470.

Jones

Taright

Boelle

. Accuracy of ICD-10 codes for surveillance of Clostridium difficile infections, France. Emerg Infect Dis. 2012;18:979-981.

Fujitani

George

Murthy

. Comparison of clinical severity score indices for Clostridium difficile infection. Infect Control Hosp Epidemiol. 2011;32:220-228.

Thacher

Clarke

. Vitamin D insufficiency. Mayo Clin Proc. 2011;86:50-60.

10.

Doi

SAR

Barendregt

Khan

Thalib

Williams

. Advances in the meta-analysis of heterogeneous clinical trials I: the inverse variance heterogeneity model. Contemp Clin Trials. 2015;45(pt A):130-138.

11.

Rucker

Schwarzer

Carpenter

Schumacher

. Undue reliance on I2 in assessing heterogeneity may mislead. BMC Med Res Methodol. 2008;8:79.

12.

Arramraju

Shalomov

John

Rubin

. Higher resolution rate of clostridia difficile enteritis in hospitalized patients with normal vitamin D levels. Gastroenterology. 2010;138:S580.

13.

Wang

Gray

Sison

. Low vitamin D level is an independent predictor of poor outcomes in Clostridium difficile–associated diarrhea. Therap Adv Gastroenterol. 2014;7:14-19.

14.

Quraishi

Litonjua

Moromizato

. Association between prehospital vitamin D status and hospital-acquired Clostridium difficile infections. JPEN J Parenter Enteral Nutr. 2015;39:47-55.

15.

Sahay

Ananthakrishnan

. Vitamin D deficiency is associated with community-acquired Clostridium difficile infection: a case-control study. BMC Infect Dis. 2014;14:661.

16.

Wong

Lee

Watkins

Haller

. Prolonged Clostridium difficile infection may be associated with vitamin D deficiency [published online January 26, 2015]. JPEN J Parenter Enteral Nutr.

17.

Zilberberg

Reske

Olsen

Yan

Dubberke

. Risk factors for recurrent Clostridium difficile infection (CDI) hospitalization among hospitalized patients with an initial CDI episode: a retrospective cohort study. BMC Infect Dis. 2014;14:306.

18.

Youssef

Ranasinghe

Grant

Peiris

. Vitamin D’s potential to reduce the risk of hospital-acquired infections. Dermatoendocrinol. 2012;4:167-175.

19.

Govani

Waljee

Stidham

Higgins

PDR

. Increasing ultraviolet light exposure is associated with reduced mortality from Clostridium difficile infection. United European Gastroenterol J. 2015;3:208-214.

20.

Grant

Giovannucci

. The possible roles of solar ultraviolet-B radiation and vitamin D in reducing case-fatality rates from the 1918–1919 influenza pandemic in the United States. Dermatoendocrinol. 2009;1:215-219.

21.

Rockett

Brookes

Udalova

Vidal

Hill

Kwiatkowski

. 1,25-Dihydroxyvitamin D3 induces nitric oxide synthase and suppresses growth of Mycobacterium tuberculosis in a human macrophage-like cell line. Infect Immun. 1998;66:5314-5321.

22.

Gombart

Borregaard

Koeffler

. Human cathelicidin antimicrobial peptide (CAMP) gene is a direct target of the vitamin D receptor and is strongly up-regulated in myeloid cells by 1,25-dihydroxyvitamin D3. Faseb J. 2005;19:1067-1077.

23.

Wang

Nestel

Bourdeau

. Cutting edge: 1,25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression. J Immunol. 2004;173:2909-2912.

24.

van Etten

Mathieu

. Immunoregulation by 1,25-dihydroxyvitamin D3: basic concepts. J Steroid Biochem Mol Biol. 2005;97:93-101.

25.

Cantorna

Mahon

. Mounting evidence for vitamin D as an environmental factor affecting autoimmune disease prevalence. Exp Biol Med. 2004;229:1136-1142.

26.

Pelajo

Lopez-Benitez

Miller

. Vitamin D and autoimmune rheumatologic disorders. Autoimmun Rev. 2010;9:507-510.

27.

Agmon-Levin

Theodor

Segal

Shoenfeld

. Vitamin D in systemic and organ-specific autoimmune diseases. Clin Rev Allergy Immunol. 2013;45:256-266.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.46 MB